treatment, and improve patient outcomes. With their extensive genetic database, GeneDx is well-equipped to contribute valuable data to the partnership with Prognos Health.
Prognos Health, on the other hand, brings their Marketplace platform to the table. This platform houses a vast amount of de-identified patient data, including lab records, health records, claims data, and pharmacy prescription data. By combining these resources, GeneDx and Prognos Health aim to provide clinicians with comprehensive and up-to-date information on rare diseases.
The ultimate goal of this strategic partnership is to shorten the treatment journey for rare disease patients. By integrating GeneDx's rare disease data into the Prognos Marketplace, clinicians will be alerted about newly diagnosed patients who may benefit from FDA-approved therapies. This will help eliminate the diagnostic odyssey that many rare disease patients face and lead to improved health outcomes.
Through this collaboration, Prognos Health intends to offer actionable insights in rare diseases that can assist clinicians in making informed decisions about treatment options. By leveraging real-world data, they hope to ensure that patients receive appropriate and timely care.
Overall, this partnership between GeneDx and Prognos Health holds great promise for rare disease patients. By harnessing the power of their respective databases and platforms